John Rother Statement on Reuters Analysis of Prescription Drug Price Increases

Apr 4, 2016
John Rother, executive director of the Campaign for Sustainable Rx Pricing, issued the following statement in response to a Reuters analysis which found prices of four of the top 10 prescription drugs in the United States have increased by more than 100 percent since 2011:
“This is further evidence that skyrocketing drug prices are more widespread than a few bad actors. When major drug companies hike prices on common prescription drugs, Americans suffer. Families are forced to decide between paying for prescriptions or paying bills, and that’s wrong.”
Rother continued, “These price increases hurt everyone, not just those taking the medications. Drug price hikes also cause job creators to pay more for employees’ health care, which, in turn, leads to fewer employees or lower wages. The broad implications of these increases are deeply troubling.”